Interventions for cognitive symptoms of dementia ‐ and the Lancet commission view on anti‐amyloid antibodies
Geir Selbaek · 2025
Read Interventions for cognitive symptoms of dementia ‐ and the Lancet commission view on anti‐amyloid antibodies by Geir Selbaek (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712664.txt.
Description
Geir Selbaek published a review paper in 2025 on treatments for the thinking symptoms of dementia, with a close look at the new anti-amyloid antibodies. Older drugs have eased symptoms modestly for three decades but do not change the disease. The new antibodies clear amyloid from the brain, yet how much that helps daily life is still debated.
Selbaek weighs trial results, expert views, and clinic reports. The older drugs are cheap, safe for most, and linked in long studies to lower death rates. The antibodies help a little on test scores but carry risks such as brain bleeding, and their costs are huge. Wider use would also demand earlier, marker-based diagnosis for many more patients.
Catalog record
| CREATOR | Geir Selbaek |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |